Found: 30
Select item for more details and to access through your institution.
Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2013, v. 36, n. 4, p. 361, doi. 10.1007/s11239-013-0870-7
- By:
- Publication type:
- Article
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0182115
- By:
- Publication type:
- Article
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.
- Published in:
- Cardiovascular Research, 2019, v. 115, n. 10, p. 1512, doi. 10.1093/cvr/cvz015
- By:
- Publication type:
- Article
Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Risk factors for type 2 MI: the usual suspects or guilt by association?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Aspirin or P2Y<sub>12</sub> inhibition: establishing the cornerstone of antiplatelet therapy after stenting.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.117.005637
- By:
- Publication type:
- Article
Short Sleep Duration, Obstructive Sleep Apnea, Shiftwork, and the Risk of Adverse Cardiovascular Events in Patients After an Acute Coronary Syndrome.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 10, p. 1, doi. 10.1161/JAHA.117.006959
- By:
- Publication type:
- Article
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Biomarkers of platelet activation and cardiovascular risk in the DAPT trial.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 3, p. 675, doi. 10.1007/s11239-020-02221-5
- By:
- Publication type:
- Article
Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2019, v. 47, n. 3, p. 353, doi. 10.1007/s11239-018-1779-y
- By:
- Publication type:
- Article
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment.
- Published in:
- European Heart Journal, 2024, v. 45, n. 19, p. 1727, doi. 10.1093/eurheartj/ehae123
- By:
- Publication type:
- Article
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
- Published in:
- European Heart Journal, 2023, v. 44, n. 4, p. 293, doi. 10.1093/eurheartj/ehac577
- By:
- Publication type:
- Article
A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
- Published in:
- European Heart Journal, 2023, v. 44, n. 3, p. 221, doi. 10.1093/eurheartj/ehac460
- By:
- Publication type:
- Article
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation.
- Published in:
- European Heart Journal, 2015, v. 36, n. 23, p. 1470, doi. 10.1093/eurheartj/ehv014
- By:
- Publication type:
- Article
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 10, p. 1006, doi. 10.1001/jama.2014.11061
- By:
- Publication type:
- Article
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1226, doi. 10.1007/s00125-021-05399-2
- By:
- Publication type:
- Article
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 6, p. 895, doi. 10.1093/eurjpc/zwaa143
- By:
- Publication type:
- Article
LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 805, doi. 10.1177/2047487320902750
- By:
- Publication type:
- Article
Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome.
- Published in:
- European Journal of Preventive Cardiology, 2018, v. 25, n. 8, p. 830, doi. 10.1177/2047487318763897
- By:
- Publication type:
- Article
Lp-PLA<sub>2</sub>, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204352
- By:
- Publication type:
- Article
Biomarkers in ACS and Heart Failure: Should Men and Women Be Interpreted Differently?
- Published in:
- Clinical Chemistry, 2014, v. 60, n. 1, p. 35, doi. 10.1373/clinchem.2013.202531
- By:
- Publication type:
- Article
Prognostic Utility of Secretory Phospholipase A<sub>2</sub> in Patients with Stable Coronary Artery Disease.
- Published in:
- Clinical Chemistry, 2011, v. 57, n. 9, p. 1311, doi. 10.1373/clinchem.2011.166520
- By:
- Publication type:
- Article